Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,037 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cangrelor in patients with percutaneous coronary intervention for acute myocardial infarction after cardiac arrest and/or with cardiogenic shock.
Zeymer U, Lober C, Richter S, Olivier CB, Huber K, Haring B, Schwimmbeck P, Andrassy M, Akin I, Cuneo A, Desch S, Thiele H, Geisler T. Zeymer U, et al. Among authors: huber k. Eur Heart J Acute Cardiovasc Care. 2023 Jul 7;12(7):462-463. doi: 10.1093/ehjacc/zuad041. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 37042356 No abstract available.
Plasma N-terminal fragment of the prohormone B-type natriuretic peptide concentrations in relation to time to treatment and Thrombolysis in Myocardial Infarction (TIMI) flow: a substudy of the Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT IV-PCI) trial.
Jarai R, Huber K, Bogaerts K, Droogne W, Ezekowitz J, Granger CB, Sinnaeve PR, Ross AM, Zeymer U, Armstrong PW, Van de Werf FJ; ASSENT IV-PCI investigators. Jarai R, et al. Among authors: huber k. Am Heart J. 2010 Jan;159(1):131-40. doi: 10.1016/j.ahj.2009.11.001. Am Heart J. 2010. PMID: 20102879 Clinical Trial.
Prediction of cardiogenic shock using plasma B-type natriuretic peptide and the N-terminal fragment of its pro-hormone [corrected] concentrations in ST elevation myocardial infarction: an analysis from the ASSENT-4 Percutaneous Coronary Intervention Trial.
Jarai R, Huber K, Bogaerts K, Sinnaeve PR, Ezekowitz J, Ross AM, Zeymer U, Armstrong PW, Van de Werf FJ; ASSENT-4 PCI investigators. Jarai R, et al. Among authors: huber k. Crit Care Med. 2010 Sep;38(9):1793-801. doi: 10.1097/CCM.0b013e3181eaaf2a. Crit Care Med. 2010. PMID: 20562693 Clinical Trial.
Efficacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial.
Zeymer U, Arntz HR, Mark B, Fichtlscherer S, Werner G, Schöller R, Zahn R, Diller F, Darius H, Dill T, Huber K. Zeymer U, et al. Among authors: huber k. Clin Res Cardiol. 2012 Apr;101(4):305-12. doi: 10.1007/s00392-011-0393-1. Epub 2011 Dec 21. Clin Res Cardiol. 2012. PMID: 22186968 Clinical Trial.
Impact of TIMI 3 patency before primary percutaneous coronary intervention for ST-elevation myocardial infarction on clinical outcome: results from the ASSENT-4 PCI study.
Zeymer U, Huber K, Fu Y, Ross A, Granger C, Goldstein P, van de Werf F, Armstrong P; (for the ASSENT-4 PCI Investigators). Zeymer U, et al. Among authors: huber k. Eur Heart J Acute Cardiovasc Care. 2012 Jun;1(2):136-42. doi: 10.1177/2048872612447069. Eur Heart J Acute Cardiovasc Care. 2012. PMID: 24062901 Free PMC article.
Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries.
Puymirat E, Battler A, Birkhead J, Bueno H, Clemmensen P, Cottin Y, Fox KA, Gorenek B, Hamm C, Huber K, Lettino M, Lindahl B, Müller C, Parkhomenko A, Price S, Quinn T, Schiele F, Simoons M, Tatu-Chitoiu G, Tubaro M, Vrints C, Zahger D, Zeymer U, Danchin N; EHS 2009 snapshot participants. Puymirat E, et al. Among authors: huber k. Eur Heart J Acute Cardiovasc Care. 2013 Dec;2(4):359-70. doi: 10.1177/2048872613497341. Epub 2013 Aug 20. Eur Heart J Acute Cardiovasc Care. 2013. PMID: 24338295 Free PMC article.
Bivalirudin is superior to heparins alone with bailout GP IIb/IIIa inhibitors in patients with ST-segment elevation myocardial infarction transported emergently for primary percutaneous coronary intervention: a pre-specified analysis from the EUROMAX trial.
Zeymer U, van 't Hof A, Adgey J, Nibbe L, Clemmensen P, Cavallini C, ten Berg J, Coste P, Huber K, Deliargyris EN, Day J, Bernstein D, Goldstein P, Hamm C, Steg PG. Zeymer U, et al. Among authors: huber k. Eur Heart J. 2014 Sep 21;35(36):2460-7. doi: 10.1093/eurheartj/ehu214. Epub 2014 May 21. Eur Heart J. 2014. PMID: 24849104 Free PMC article. Clinical Trial.
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force.
Gorenek B, Lundqvist CB, Terradellas JB, Camm AJ, Hindricks G, Huber K, Kirchhof P, Kuck KH, Kudaiberdieva G, Lin T, Raviele A, Santini M, Tilz RR, Valgimigli M, Vos MA, Vrints C, Zeymer U. Gorenek B, et al. Among authors: huber k. Eur Heart J Acute Cardiovasc Care. 2015 Aug;4(4):386. doi: 10.1177/2048872614550583. Epub 2014 Sep 1. Eur Heart J Acute Cardiovasc Care. 2015. PMID: 25178689 Review. No abstract available.
2,037 results